Abstract
While clinical guidelines clearly define mechanisms for asthma diagnosis based upon history, lung function testing, symptoms, and physical examination, surveillance for asthma is much less straightforward. Epidemiologists have long debated the best means of assessing the scope and burden of asthma, seeking to reduce the potential for confounding introduced by differential means of diagnosis and even slight differences in surveillance questions, both of which can bias surveillance results such that we over- or undercount cases. This chapter will provide an overview of asthma epidemiology in the USA and internationally, as well as review of the data and findings from the major surveillance systems, a discussion of a networked approach to the science and evaluation of therapeutic treatments using the exemplar of the Inner-City Asthma Network, and assessment of public health implications.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akinbami LJ, Moorman JE, Bailey C et al (2012a) Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS data brief, no 94. National Center for Health Statistics, Hyattsville, MD
Akinbami LJ, Moorman JE, Liu, X (2012) Asthma prevalence, health care use, and mortality: United States, 2005–2009. National Health Statistics Reports, no 32. National Center for Health Statistics, Hyattsville, MD
Asthma and Allergy Foundation of America. Asthma facts and figures. Available at http://www.aafa.org/display.cfm?id=8&sub=42. Accessed 15 Sept 12
BedirhanÜstün T, Chatterji S, Mechbal A, Murray C, WHS Collaborating Groups (2003) Health systems performance assessment: debates, methods and empiricism. In: Murray C, Evans D (eds) The world health surveys. Health systems performance assessment: debates, methods and empiricism. World Health Organization, Geneva, pp 797–808
Busse WW (2010) The national institutes of allergy and infectious diseases networks on asthma in inner-city children: an approach to improved care. J Allergy Clin Immunol 125(3):529–537
CDC (2001) Updated guidelines for evaluating public health surveillance systems. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm. Accessed 28 Aug 12
CDC (2011) Asthma in the US: growing every year. CDC vital signs
CDC (2012) Asthma Surveillance Data. Available at: http://www.cdc.gov/asthma/asthmadata.htm. Accessed 20 Sept 12
CDC, National Asthma Control Program (2012) Asthma’s Impact on the Nation. Available at: http://www.cdc.gov/asthma/impacts_nation/AsthmaFactSheet.pdf. Accessed 20 Sept 12
Cloutier MM et al (2005) Use of asthma guidelines by primary care providers to reduce hospitalizations and emergency department visits in poor, minority, urban children. J Pediatr 146:591–597
European Community Respiratory Health Survey (2012) http://www.ecrhs.org/home.htm. Accessed 20 Sept 2012
GINA (2002) Global strategy for asthma management and prevention. National Institutes of Health, National Heart, Lung, and Blood Institute, Washington, DC
Gorina Y (2012) QuickStats: asthma* death rates, by race and age group—United States, 2007–2009. MMWR 61(17):315
ISAAC (2012) http://isaac.auckland.ac.nz/story/index.html. Accessed 9 Sept 12
Masoli M, Fabian D, Holt S, Beasley R (2004) Global Initiative for Asthma (GINA) Program: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59(5):469–478
Moorman JE, Zahran HS, Truman BI, Molla MT (2011) Division of environmental hazards and health effects, national center for environmental health, CDC. Current asthma prevalence—United States, 2006–2008. MMWR 60(Suppl):84–86
National Heart, Lung, and Blood Institute (2007) Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, NHLBI, 2007. Available at http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed 26 Sept 12
Petronella SA, Bricker S, Brown C, Perrotta D, Brooks EG (2006) Addressing asthma in Texas: development of a school-based asthma surveillance program for Texas elementary schools: report of findings. J Sch Health 76(6):227–234
Petronella SA, Ellis KC (2003) Asthma epidemiology, case finding and the role of asthma coalitions. Nurs Clin North Am 38:1–11
Schiller JS, Lucas JW, Ward BW, Peregoy JA (2012) Summary health statistics for U.S. adults: National Health Interview Survey, 2010. National Center for Health Statistics. Vital Health Stat 10(252)
Szefler SJ, Gergen PJ, Mitchell H, Morgan W (2010) Achieving asthma control in the inner city: do the National Institutes of Health Asthma Guidelines really work? J Allergy Clin Immunol 125:521–526
To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet L-P (2012) Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 12:204
World Health Organization (2007) Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach
Zahran HS, Bailey C, Garbe P (2011) Division of environmental hazards and health effects, National Center for Environmental Health, CDC. Vital signs: asthma prevalence, disease characteristics, and self-management education—United States, 2001—2009. MMWR 60(17):547–552
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Croisant, S. (2014). Epidemiology of Asthma: Prevalence and Burden of Disease. In: Brasier, A. (eds) Heterogeneity in Asthma. Advances in Experimental Medicine and Biology, vol 795. Humana Press, Boston, MA. https://doi.org/10.1007/978-1-4614-8603-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8603-9_2
Published:
Publisher Name: Humana Press, Boston, MA
Print ISBN: 978-1-4614-8602-2
Online ISBN: 978-1-4614-8603-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)